COST-EFFECTIVENESS ANALYSIS OF THE CORRECT VS IMPROPER USE OF RIVASTIGMINE TRANSDERMAL PATCH IN PATIENTS WITH ALZHEIMER'S DISEASE IN COLOMBIA

被引：0
|
作者：
Romero, M. [1 ]
Cuellar, K. [1 ]
Acero, G. [1 ]
Cuadros, R. [2 ]
Patino, A. [3 ]
机构：
[1] Grupo Proyectame, Bogota, DC, Colombia
[2] Asociac Colombiana Gerontol & Geriatria, Bogota, DC, Colombia
[3] Knight Therapeut Colombia, Bogota, DC, Colombia
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE116
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN
    Mesterton, J.
    By, A.
    Sandelin, R.
    Jonsson, L.
    VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [42] A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease
    D'Onofrio, Grazia
    Sancarlo, Daniele
    Addante, Filomena
    Ciccone, Filomena
    Cascavilla, Leandro
    Paris, Francesco
    Elia, Anna Chiara
    Nuzzaci, Claudia
    Picoco, Michele
    Greco, Antonio
    Panza, Francesco
    Pilotto, Alberto
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (09) : 965 - 975
  • [43] Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients
    Lefevre, G.
    Sedek, G.
    Jhee, S. S.
    Leibowitz, M. T.
    Huang, H-LA
    Enz, A.
    Maton, S.
    Ereshefsky, L.
    Pommier, F.
    Schmidli, H.
    Appel-Dingemanse, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 106 - 114
  • [44] A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch
    Vagenas, Vassileios
    Vlachos, Georgios S.
    Vlachou, Nikoleta
    Liakopoulos, Dimitrios
    Kalaitzakis, Michail E.
    Vikelis, Michail
    SAGE OPEN MEDICINE, 2015, 3
  • [45] COST-EFFECTIVENESS OF ADUCANUMAB VERSUS DONEPEZIL FOR PATIENTS WITH EARLY ALZHEIMER'S DISEASE
    Xiong, X.
    Li, M.
    Lu, Z. K.
    VALUE IN HEALTH, 2023, 26 (06) : S85 - S85
  • [46] Treatment of institutionalized patients with Alzheimer's disease with quetiapine: A cost-effectiveness evaluation
    Getsios, D
    O'Brien, J
    Caro, JJ
    Pesa, J
    VALUE IN HEALTH, 2005, 8 (03) : 254 - 254
  • [47] Donepezil and rivastigmine in the treatment of Alzheimer's disease: A best-evidence synthesis of the published data on their efficacy and cost-effectiveness
    Wolfson, C
    Oremus, M
    Shukla, V
    Momoli, F
    Demers, L
    Perrault, A
    Moride, Y
    CLINICAL THERAPEUTICS, 2002, 24 (06) : 862 - 886
  • [48] Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (01) : 73 - 78
  • [49] Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer's Disease
    Lin, Chung-Hsien
    Fann, Jean Ching-Yuan
    Chen, Sam Li-Sheng
    Chen, Hsiu-Hsi
    Yang, Kuen-Cheh
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (06) : 495 - 504
  • [50] Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer's disease in Brazil
    da Silva, Luciana R.
    Vianna, Cid M. M.
    Mosegui, Gabriela B. G.
    Peregrino, Antonio A. F.
    Marinho, Valeska
    Laks, Jerson
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2019, 41 (03) : 218 - 224
12345